Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and Cancer of Ovary

17 alpha-hydroxyprogesterone caproate has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashkenazy, M; Czernobilsky, B; Kessler, I; Lancet, M; Nahshoni, A1

Other Studies

1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Cancer of Ovary

ArticleYear
Ovarian tumors in pregnancy.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1988, Volume: 27, Issue:1

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Abortion, Spontaneous; Adult; Combined Modality Therapy; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Ovariectomy; Pregnancy; Pregnancy Complications, Neoplastic

1988